Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000885590-12-000033)

Filing Details

Accession Number:: 0000885590-12-000033
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-05-24 17:00:48
Reporting Period:: 2012-05-22

Filing Date:: 2012-05-24
Accepted Time:: 2012-05-24 17:00:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Valeant Pharmaceuticals International Inc.	VRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1343811	Ann Norma Provencio	4787 Levy Road Montreal A8 H4R 2P9		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2012-05-22	500	$47.75	164,430	No	4	P	Direct
Common Stock, No Par Value	Acquisiton	2012-05-22	3,000	$47.74	167,430	No	4	P	Direct
Common Stock, No Par Value	Acquisiton	2012-05-22	725	$47.75	168,155	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Purchased 500 shares into an IRA account.
This number represents common shares purchased and other equity awards that were previously reported in Table 1.
Purchased 3000 shares in a personal brokerage account.
Purchased 725 shares into a 401k account.